Terms: = Lymphoma AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
128 results:
1. Interventional treatment of refractory non-traumatic chylous effusions in patients with lymphoproliferative disorders.
Wagenpfeil J; Hoß K; Henkel A; Kütting D; Luetkens JA; Feldmann G; Brossart P; Attenberger UI; Pieper CC
Clin Exp Med; 2024 Mar; 24(1):63. PubMed ID: 38554229
[TBL] [Abstract] [Full Text] [Related]
2. The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.
Pedersen MA; Gormsen LC; Jakobsen LH; Eyre TA; Severinsen MT; Baech J; Dann EJ; Knapp A; Sahin D; Vestergaard P; El-Galaly TC; Jensen P
Br J Haematol; 2024 Apr; 204(4):1271-1278. PubMed ID: 37957542
[TBL] [Abstract] [Full Text] [Related]
3. Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell lymphoma.
Lin LH; Ghasemi M; Burke SM; Mavis CK; Nichols JR; Torka P; Mager DE; Hernandez-Ilizaliturri FJ; Goey AKL
Target Oncol; 2023 Sep; 18(5):685-695. PubMed ID: 37632592
[TBL] [Abstract] [Full Text] [Related]
4. Patients with enteropathy-associated T-cell lymphoma in the United States from 2000 to 2018: SEER data-base analysis.
Awad AK; Awan RU; Awad AK; Nabeel A; Dar S; Abegunde AT
Cancer Treat Res Commun; 2023; 36():100745. PubMed ID: 37499419
[TBL] [Abstract] [Full Text] [Related]
5. Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race.
Li S; Suehs BT; Fu A; Sangaré L; Kim C; Gastanaga VM; Liu J; Yan H; Xu Y; Mikhael J
Clin Lymphoma Myeloma Leuk; 2023 Aug; 23(8):616-625. PubMed ID: 37258396
[TBL] [Abstract] [Full Text] [Related]
6. [The efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitors in the treatment of Philadelphia-chromosomal-positive acute lymphoblastic leukemia].
Wang H; Zhao T; Hu LJ; Li ZR; Jiang H; Qin YZ; Lai YY; Shi HX; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2022 Jul; 43(7):550-556. PubMed ID: 36709131
[No Abstract] [Full Text] [Related]
7. Clinical course, long-term outcomes, and chemotherapy toxicity profile in B-cell Non-Hodgkin lymphoma in children: Single institution experience of Pakistan.
Rehman P; Wali RM
J Pak Med Assoc; 2022 Oct; 72(10):1988-1993. PubMed ID: 36660986
[TBL] [Abstract] [Full Text] [Related]
8. Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas.
Sengar M; Jain H; Shet T; Sridhar E; Gota V; Rangarajan V; Laskar SS; Alahari A; Thorat J; Agarwal A; Sharma N; Gupta H; Kannan S; Kumar S; Nayak L; Menon H; Gujral S; Bagal B
Br J Haematol; 2023 Feb; 200(4):429-439. PubMed ID: 36323643
[TBL] [Abstract] [Full Text] [Related]
9. [Mid-term efficacy of China Net Childhood lymphoma-mature B-cell lymphoma 2017 regimen in the treatment of pediatric Burkitt lymphoma].
Zhang M; Wu P; Duan YL; Jin L; Yang J; Huang S; Liu Y; Hu B; Zhai XW; Wang HS; Fu Y; Li F; Yang XM; Liu AS; Qin S; Yuan XJ; Dong YS; Liu W; Zhou JW; Zhang LP; Jia YP; Wang J; Qu LJ; Dai YP; Guan GT; Sun LR; Jiang J; Liu R; Jin RM; Wang ZJ; Wang XG; Zhang BX; Chen KL; Zhuang SQ; Zhang J; Zhou CJ; Gao ZF; Zheng MC; Zhang Y
Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1011-1018. PubMed ID: 36207847
[No Abstract] [Full Text] [Related]
10. The cost-effectiveness of brigatinib in adult patients with ALK inhibitor-naive ALK-positive non-small cell lung cancer from a US perspective.
Cranmer H; Kearns I; Young M; Humphries MJ; Trueman D
J Manag Care Spec Pharm; 2022 Sep; 28(9):970-979. PubMed ID: 36001099
[No Abstract] [Full Text] [Related]
11. Rapamycin inhibits the progression of human acute myeloid leukemia by regulating the circ_0094100/miR-217/ATP1B1 axis.
Cao J; Huang S; Li X
Exp Hematol; 2022; 112-113():60-69.e2. PubMed ID: 35901982
[TBL] [Abstract] [Full Text] [Related]
12. Mucormycosis in Children With Hematologic Malignancies: A Case Series and Review of the Literature.
Loeffen YGT; Scharloo F; Goemans BF; Heitink-Polle KMJ; Lindemans CA; van der Bruggen T; Hagen F; Wolfs TFW
Pediatr Infect Dis J; 2022 Sep; 41(9):e369-e376. PubMed ID: 35703287
[TBL] [Abstract] [Full Text] [Related]
13. [Efficacy of Chimeric Antigen Receptor T Cell in the treatment of Refractory/Recurrent B Acute Lymphocytic Leukemia in Children].
Yang F; Wang TY; DU WW; He HL; Xiao PF; Lu Y; Hu SY; Li BS; Lu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):718-725. PubMed ID: 35680795
[TBL] [Abstract] [Full Text] [Related]
14. Association of High-Deductible Health Plan Enrollment With Spending on and Use of Lenalidomide Therapy Among Commercially Insured Patients With Multiple Myeloma.
Jazowski SA; Wilson L; Dusetzina SB; Zafar SY; Zullig LL
JAMA Netw Open; 2022 Jun; 5(6):e2215720. PubMed ID: 35671056
[TBL] [Abstract] [Full Text] [Related]
15. Activity and toxicity of intramuscular 1000 iu/m
Sidhu J; Masurekar AN; Gogoi MP; Fong C; Ioannou T; Lodhi T; Parker C; Liu J; Kirkwood AA; Moorman AV; Das K; Goulden NJ; Vora A; Saha V; Krishnan S
Br J Haematol; 2022 Jul; 198(1):142-150. PubMed ID: 35348200
[TBL] [Abstract] [Full Text] [Related]
16. Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies.
Cordo' V; Meijer MT; Hagelaar R; de Goeij-de Haas RR; Poort VM; Henneman AA; Piersma SR; Pham TV; Oshima K; Ferrando AA; Zaman GJR; Jimenez CR; Meijerink JPP
Nat Commun; 2022 Feb; 13(1):1048. PubMed ID: 35217681
[TBL] [Abstract] [Full Text] [Related]
17. Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
Gotti G; Stevenson K; Kay-Green S; Blonquist TM; Mantagos JS; Silverman LB; Place AE
Pediatr Blood Cancer; 2022 Apr; 69(4):e29542. PubMed ID: 35187841
[TBL] [Abstract] [Full Text] [Related]
18. Systematic review and pooled analysis of survival outcomes in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia who have undergone haematopoietic stem cell transplant.
Russell-Smith TA; Chadda S; LeReun C; Bajko P; Doogan E
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):975-995. PubMed ID: 35179764
[TBL] [Abstract] [Full Text] [Related]
19. Surgical Management of Traumatic Brachial Plexus Injuries in the Pediatric Population.
Carlson Strother C; Joslyn-Eastman N; Loosbrok MF; Pulos N; Bishop AT; Spinner RJ; Shin AY
World Neurosurg; 2022 May; 161():e244-e251. PubMed ID: 35124276
[TBL] [Abstract] [Full Text] [Related]
20. Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study.
Joelsson J; Wästerlid T; Rosenquist R; Jakobsen LH; El-Galaly TC; Smedby KE; Eloranta S
Blood Adv; 2022 Apr; 6(8):2657-2666. PubMed ID: 35042239
[TBL] [Abstract] [Full Text] [Related]
[Next]
